Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19: Well-Being in Cancer Patients With Neuropathy Who Participated in Prior Clinical Trials

NCT04650178 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT04650178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04650178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19: Well-Being in Cancer Patients With Neuropathy Who Participated in Prior Clinical Trials
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Active, not recruiting
Start date
May 26, 2020
Completion date
April 30, 2027
Enrollment
274 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 infection, hematopoietic and lymphoid cell neoplasm, malignant solid neoplasm, neuropathy